Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

23847studies shown

Showing 23,041-23,052 of 23,847

Drug study icon

CompletedNCT00736021

Treatment of PTSD With High Doses of Escitalopram

This summary needs review. Please check the official study record and contact the research team for details.

In Jerusalem

PTSDDrugFrom 21 Years to 65 Years

Countries: Israel
Sponsor: Hadassah Medical Organization
Condition: PTSD

Device study icon

CompletedNCT02451371

Treatment of Refractory Auditory Verbal Hallucinations With tDCS in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Seoul

SchizophreniaDeviceFrom 19 Years to 50 Years

Countries: South Korea
Sponsor: Seoul National University Hospital
Condition: Schizophrenia

Drug study icon

CompletedNCT00375050

Treatment of Refractory Schizophrenia With Riluzole

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Yale University
Condition: Schizophrenia

Drug study icon

TerminatedNCT00725270

Treatment of Schizoaffective Disorder Using Mifepristone

This summary needs review. Please check the official study record and contact the research team for details.

In Stanford

Depression, SchizophreniaDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Stanford University
Condition: Depression, Schizophrenia

Drug study icon

CompletedNCT00498550

Treatment of Schizophrenia and Comorbid Addiction: Comparing Clozapine to Treatment-as-Usual

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Los Angeles

Schizophrenia, AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Dartmouth-Hitchcock Medical Center
Condition: Schizophrenia, Addiction

Behavioral study icon

CompletedNCT00051233

Treatment of Schizophrenia Through Internet-Based Psychoeducation

This summary needs review. Please check the official study record and contact the research team for details.

In Pittsburgh

SchizophreniaBehavioralFrom 14 Years to 55 Years

Countries: United States
Sponsor: University of Pittsburgh
Condition: Schizophrenia

Drug study icon

CompletedNCT00419146

Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants

This summary needs review. Please check the official study record and contact the research team for details.

In Oslo

SchizophreniaDrugFrom 18 Years to 40 Years

Countries: Norway
Sponsor: University Hospital, Aker
Condition: Schizophrenia

Drug study icon

CompletedNCT02118610

Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.

In Catonsville

SchizophreniaDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

Drug study icon

CompletedNCT00579670

Treatment of Schizophrenic people with Ziprasidone

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Athens

SchizophreniaDrugOver 18 Years

Countries: Greece
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition: Schizophrenia

Drug study icon

CompletedNCT00796302

Treatment of Severe Childhood Aggression (The TOSCA Study)

This study exists to understand whether a digital app or remote support tool is both safe enough and useful enough to take further. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Stony Brook

ADHDDrugFrom 6 Years to 12 Years

Countries: United States
Sponsor: Michael Aman
Condition: ADHD

Behavioral study icon

CompletedEUCTR NCT02761161

TREATMENT OF SLEEP DISTURBANCES IN TRAUMA-AFFECTED REFUGEES – A CONTROLLED study

This study is completed in Denmark. It focuses on PTSD.

In Copenhagen

PTSDBehavioralOver 18 Years

Countries: Denmark
Sponsor: Competence Centre for Transcultural Psychiatry
Condition: PTSD

Drug study icon

CompletedNCT00937235

Treatment of Smoking Among Individuals With PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Philadelphia

PTSD, AddictionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: PTSD, Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.